These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 37069649)

  • 1. Novel insights into the multifaceted roles of m
    Tang J; Zhang J; Lu Y; He J; Wang H; Liu B; Tu C; Li Z
    Biomark Res; 2023 Apr; 11(1):42. PubMed ID: 37069649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insight into the functions of N
    He Y; Du X; Chen M; Han L; Sun J
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
    Zhang S; Shao Y; Li D; Li C
    Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
    Cusenza VY; Tameni A; Neri A; Frazzi R
    Front Oncol; 2023; 13():1063636. PubMed ID: 36969033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental exposures and RNA N6-Methyladenosine modified long Non-Coding RNAs.
    Cayir A
    Crit Rev Toxicol; 2020 Sep; 50(8):641-649. PubMed ID: 32924714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into mutual regulation between N
    Zhang N; Sun Y; Mei Z; He Z; Gu S
    Cancer Cell Int; 2023 Jun; 23(1):127. PubMed ID: 37365581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functions of N6-methyladenosine modification in lncRNAs.
    He RZ; Jiang J; Luo DX
    Genes Dis; 2020 Dec; 7(4):598-605. PubMed ID: 33335959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of M
    Lan Y; Liu B; Guo H
    Mol Ther Nucleic Acids; 2021 Jun; 24():768-779. PubMed ID: 33996258
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
    Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
    Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights on the interplays between m
    Su T; Liu J; Zhang N; Wang T; Han L; Wang S; Yang M
    Front Cell Dev Biol; 2023; 11():1157797. PubMed ID: 37404673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging roles of N6-methyladenosine (m6A)-modified long non-coding RNAs in human cancers.
    Liu J; Zhao W; Zhang L; Wang X
    Cell Death Discov; 2022 May; 8(1):255. PubMed ID: 35534472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma.
    Zhang W; Wu W; Meng Q; Yang L; Yuan J; Tian Z; Ding R; Zhang X; Wang J; Tao K
    Front Oncol; 2022; 12():907399. PubMed ID: 35936671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Long Non-coding RNAs Modified by m
    Xie SJ; Tao S; Diao LT; Li PL; Chen WC; Zhou ZG; Hu YX; Hou YR; Lei H; Xu WY; Chen WJ; Peng YW; Zhang Q; Xiao ZD
    Front Cell Dev Biol; 2021; 9():762669. PubMed ID: 34722547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of long non-coding RNAs in gastric cancer.
    Zhou Z; Lin Z; Pang X; Tariq MA; Ao X; Li P; Wang J
    Oncotarget; 2018 Apr; 9(27):19443-19458. PubMed ID: 29721215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
    Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
    Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional analysis of N6-methyladenine (m
    Xu D; Xu Z; Bi X; Cai J; Cao M; Zheng D; Chen L; Li P; Wang H; Wu D; Yang J; Li K
    Cancer Med; 2023 Jan; 12(2):2104-2116. PubMed ID: 35789547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus.
    Wu J; Deng LJ; Xia YR; Leng RX; Fan YG; Pan HF; Ye DQ
    Mol Immunol; 2022 Mar; 143():77-84. PubMed ID: 35051888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging roles of N6-methyladenosine (m
    Wang Y; Zhang Y; Du Y; Zhou M; Hu Y; Zhang S
    Cell Biosci; 2020 Nov; 10(1):136. PubMed ID: 33292526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.